Arca Biopharma | ABIO - PE Price to Earnings


Arca Biopharma reported 27.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Grifols 11.2 1.08 Dec/2025
Laboratory Of America 20.86 10.79 Dec/2025
Otsuka Holdings 12.07 3.16 Dec/2025
Pfizer 14.48 5.18 Dec/2025
United Therapeutics 17.32 1.62 Dec/2025